

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | presynaptic membrane assembly (GO:0097105) | 4.61185302 |
| 2 | postsynaptic membrane organization (GO:0001941) | 4.13338480 |
| 3 | presynaptic membrane organization (GO:0097090) | 4.08745541 |
| 4 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.05044780 |
| 5 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.83988626 |
| 6 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.79728873 |
| 7 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.74517221 |
| 8 | protein K11-linked deubiquitination (GO:0035871) | 3.71656069 |
| 9 | positive regulation of granulocyte differentiation (GO:0030854) | 3.58731880 |
| 10 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.55815288 |
| 11 | L-fucose catabolic process (GO:0042355) | 3.53489271 |
| 12 | fucose catabolic process (GO:0019317) | 3.53489271 |
| 13 | L-fucose metabolic process (GO:0042354) | 3.53489271 |
| 14 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 3.49863245 |
| 15 | regulation of memory T cell differentiation (GO:0043380) | 3.46406502 |
| 16 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.44202625 |
| 17 | neuron cell-cell adhesion (GO:0007158) | 3.35017274 |
| 18 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.26991176 |
| 19 | positive regulation of B cell differentiation (GO:0045579) | 3.25683319 |
| 20 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.24298673 |
| 21 | regulation of gamma-delta T cell activation (GO:0046643) | 3.17317889 |
| 22 | synaptic transmission, glutamatergic (GO:0035249) | 3.15630179 |
| 23 | cranial nerve structural organization (GO:0021604) | 3.12891235 |
| 24 | righting reflex (GO:0060013) | 3.12329633 |
| 25 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 3.12039959 |
| 26 | organelle membrane fusion (GO:0090174) | 3.06541189 |
| 27 | cAMP catabolic process (GO:0006198) | 3.06464535 |
| 28 | vocalization behavior (GO:0071625) | 3.05984942 |
| 29 | activated T cell proliferation (GO:0050798) | 3.05631860 |
| 30 | neural tube formation (GO:0001841) | 3.05380969 |
| 31 | protein localization to synapse (GO:0035418) | 3.04891462 |
| 32 | cyclic nucleotide catabolic process (GO:0009214) | 3.04497129 |
| 33 | facial nerve structural organization (GO:0021612) | 3.04347397 |
| 34 | interferon-gamma production (GO:0032609) | 3.03349924 |
| 35 | DNA deamination (GO:0045006) | 3.03327552 |
| 36 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.01976355 |
| 37 | negative regulation of mast cell activation (GO:0033004) | 3.01704715 |
| 38 | glutamate receptor signaling pathway (GO:0007215) | 3.01497752 |
| 39 | startle response (GO:0001964) | 3.00987279 |
| 40 | regulation of hexokinase activity (GO:1903299) | 3.00439199 |
| 41 | regulation of glucokinase activity (GO:0033131) | 3.00439199 |
| 42 | detection of light stimulus involved in sensory perception (GO:0050962) | 2.99036782 |
| 43 | detection of light stimulus involved in visual perception (GO:0050908) | 2.99036782 |
| 44 | signal peptide processing (GO:0006465) | 2.98569063 |
| 45 | regulation of glutamate receptor signaling pathway (GO:1900449) | 2.95016623 |
| 46 | long-term memory (GO:0007616) | 2.91464036 |
| 47 | histone H3-K4 trimethylation (GO:0080182) | 2.90902641 |
| 48 | regulation of germinal center formation (GO:0002634) | 2.87612795 |
| 49 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 2.87315198 |
| 50 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.86588118 |
| 51 | negative regulation of cell killing (GO:0031342) | 2.86588118 |
| 52 | positive regulation of defense response to virus by host (GO:0002230) | 2.82820805 |
| 53 | cellular extravasation (GO:0045123) | 2.82243035 |
| 54 | cell differentiation involved in metanephros development (GO:0072202) | 2.82169999 |
| 55 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.80468831 |
| 56 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.79083279 |
| 57 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.79083279 |
| 58 | L-amino acid import (GO:0043092) | 2.78712328 |
| 59 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.76684681 |
| 60 | regulation of B cell differentiation (GO:0045577) | 2.76185394 |
| 61 | central nervous system neuron axonogenesis (GO:0021955) | 2.76064437 |
| 62 | establishment of protein localization to Golgi (GO:0072600) | 2.75346147 |
| 63 | neuronal action potential propagation (GO:0019227) | 2.72574681 |
| 64 | neutrophil activation involved in immune response (GO:0002283) | 2.72153631 |
| 65 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 2.71758551 |
| 66 | regulation of mast cell activation (GO:0033003) | 2.71508841 |
| 67 | neuron-neuron synaptic transmission (GO:0007270) | 2.71464259 |
| 68 | photoreceptor cell maintenance (GO:0045494) | 2.71422827 |
| 69 | central nervous system projection neuron axonogenesis (GO:0021952) | 2.71146646 |
| 70 | adaptation of signaling pathway (GO:0023058) | 2.71133642 |
| 71 | negative regulation of T cell mediated immunity (GO:0002710) | 2.70491783 |
| 72 | mast cell activation (GO:0045576) | 2.69938151 |
| 73 | indolalkylamine metabolic process (GO:0006586) | 2.69928387 |
| 74 | regulation of synaptic vesicle exocytosis (GO:2000300) | 2.68956164 |
| 75 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.68413996 |
| 76 | autophagic vacuole fusion (GO:0000046) | 2.67857475 |
| 77 | negative T cell selection (GO:0043383) | 2.65345724 |
| 78 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 2.64917436 |
| 79 | locomotory exploration behavior (GO:0035641) | 2.63347229 |
| 80 | mast cell degranulation (GO:0043303) | 2.63121391 |
| 81 | mast cell activation involved in immune response (GO:0002279) | 2.63121391 |
| 82 | positive regulation of T-helper 1 type immune response (GO:0002827) | 2.62317446 |
| 83 | indole-containing compound catabolic process (GO:0042436) | 2.62164453 |
| 84 | indolalkylamine catabolic process (GO:0046218) | 2.62164453 |
| 85 | tryptophan catabolic process (GO:0006569) | 2.62164453 |
| 86 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.61504656 |
| 87 | negative regulation of translation, ncRNA-mediated (GO:0040033) | 2.61496227 |
| 88 | regulation of translation, ncRNA-mediated (GO:0045974) | 2.61496227 |
| 89 | negative regulation of translation involved in gene silencing by miRNA (GO:0035278) | 2.61496227 |
| 90 | regulation of synaptic transmission, GABAergic (GO:0032228) | 2.60726464 |
| 91 | energy homeostasis (GO:0097009) | 2.60575051 |
| 92 | definitive hemopoiesis (GO:0060216) | 2.60447588 |
| 93 | transmission of nerve impulse (GO:0019226) | 2.59301083 |
| 94 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.59216727 |
| 95 | mechanosensory behavior (GO:0007638) | 2.59089320 |
| 96 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 2.58702769 |
| 97 | mesenchymal cell differentiation involved in renal system development (GO:2001012) | 2.58455152 |
| 98 | mesenchymal cell differentiation involved in kidney development (GO:0072161) | 2.58455152 |
| 99 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.58107840 |
| 100 | negative thymic T cell selection (GO:0045060) | 2.57976332 |
| 101 | developmental pigmentation (GO:0048066) | 2.57828556 |
| 102 | piRNA metabolic process (GO:0034587) | 2.57320103 |
| 103 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 2.56482986 |
| 104 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.56159914 |
| 105 | regulation of pigment cell differentiation (GO:0050932) | 2.55968599 |
| 106 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.54366388 |
| 107 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 2.53882505 |
| 108 | phosphatidylinositol acyl-chain remodeling (GO:0036149) | 2.53826123 |
| 109 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.53701296 |
| 110 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.52720416 |
| 111 | immunoglobulin mediated immune response (GO:0016064) | 2.51945208 |
| 112 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 2.51156056 |
| 113 | positive regulation of membrane potential (GO:0045838) | 2.50371303 |
| 114 | inositol phosphate catabolic process (GO:0071545) | 2.49062742 |
| 115 | positive regulation of mast cell activation (GO:0033005) | 2.49052294 |
| 116 | protein localization to cilium (GO:0061512) | 2.48637433 |
| 117 | G-protein coupled receptor internalization (GO:0002031) | 2.48598832 |
| 118 | response to pheromone (GO:0019236) | 2.48476842 |
| 119 | regulation of synaptic vesicle transport (GO:1902803) | 2.48403807 |
| 120 | dentate gyrus development (GO:0021542) | 2.47482806 |
| 121 | cellular response to interleukin-15 (GO:0071350) | 2.47217212 |
| 122 | monoubiquitinated protein deubiquitination (GO:0035520) | 2.47147060 |
| 123 | protein targeting to Golgi (GO:0000042) | 2.47123319 |
| 124 | microglial cell activation (GO:0001774) | 2.47003480 |
| 125 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 2.45263684 |
| 126 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 2.44833923 |
| 127 | regulation of postsynaptic membrane potential (GO:0060078) | 2.44475430 |
| 128 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.44013567 |
| 129 | regulation of ER to Golgi vesicle-mediated transport (GO:0060628) | 2.43498120 |
| 130 | B cell receptor signaling pathway (GO:0050853) | 2.43239182 |
| 131 | prenylation (GO:0097354) | 2.43024872 |
| 132 | protein prenylation (GO:0018342) | 2.43024872 |
| 133 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.42072306 |
| 134 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.42045426 |
| 135 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.41874115 |
| 136 | cellular response to exogenous dsRNA (GO:0071360) | 2.41856267 |
| 137 | positive regulation of dendritic spine development (GO:0060999) | 2.41030497 |
| 138 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.40601850 |
| 139 | phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092) | 2.40595840 |
| 140 | positive regulation of CREB transcription factor activity (GO:0032793) | 2.40471433 |
| 141 | cellular response to ethanol (GO:0071361) | 2.40120632 |
| 142 | cranial nerve morphogenesis (GO:0021602) | 2.38989961 |
| 143 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 2.38939649 |
| 144 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 2.38571492 |
| 145 | regulation of synapse assembly (GO:0051963) | 2.38496561 |
| 146 | histone mRNA catabolic process (GO:0071044) | 2.38446486 |
| 147 | regulation of respiratory system process (GO:0044065) | 2.38282251 |
| 148 | tryptophan metabolic process (GO:0006568) | 2.38150613 |
| 149 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 2.38087385 |
| 150 | DNA double-strand break processing (GO:0000729) | 2.37866334 |
| 151 | synaptic vesicle exocytosis (GO:0016079) | 2.37797707 |
| 152 | platelet dense granule organization (GO:0060155) | 2.37316619 |
| 153 | neutrophil mediated immunity (GO:0002446) | 2.36929278 |
| 154 | regulation of granulocyte differentiation (GO:0030852) | 2.36611939 |
| 155 | positive regulation of synapse assembly (GO:0051965) | 2.35768710 |
| 156 | auditory behavior (GO:0031223) | 2.35695687 |
| 157 | regulation of T-helper 1 type immune response (GO:0002825) | 2.35295722 |
| 158 | cytidine catabolic process (GO:0006216) | 2.35174066 |
| 159 | cytidine deamination (GO:0009972) | 2.35174066 |
| 160 | cytidine metabolic process (GO:0046087) | 2.35174066 |
| 161 | regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645) | 2.35109519 |
| 162 | cerebral cortex radially oriented cell migration (GO:0021799) | 2.34691418 |
| 163 | anatomical structure arrangement (GO:0048532) | 2.34625723 |
| 164 | kynurenine metabolic process (GO:0070189) | 2.34043476 |
| 165 | regulation of timing of cell differentiation (GO:0048505) | 2.33413023 |
| 166 | negative regulation of B cell proliferation (GO:0030889) | 2.33279846 |
| 167 | positive regulation of antigen processing and presentation (GO:0002579) | 2.32993980 |
| 168 | DNA demethylation (GO:0080111) | 2.31304283 |
| 169 | inositol phosphate dephosphorylation (GO:0046855) | 2.30769005 |
| 170 | phosphorylated carbohydrate dephosphorylation (GO:0046838) | 2.30769005 |
| 171 | response to auditory stimulus (GO:0010996) | 2.30721442 |
| 172 | reflex (GO:0060004) | 2.30195542 |
| 173 | T cell migration (GO:0072678) | 2.29963549 |
| 174 | amino acid import (GO:0043090) | 2.29435260 |
| 175 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.29262545 |
| 176 | regulation of male gonad development (GO:2000018) | 2.28669158 |
| 177 | retinal cone cell development (GO:0046549) | 2.28119852 |
| 178 | mechanoreceptor differentiation (GO:0042490) | 2.27875028 |
| 179 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 2.26463860 |
| 180 | eye photoreceptor cell development (GO:0042462) | 2.25955562 |
| 181 | positive regulation of meiosis (GO:0045836) | 2.25476620 |
| 182 | photoreceptor cell differentiation (GO:0046530) | 2.23309161 |
| 183 | eye photoreceptor cell differentiation (GO:0001754) | 2.23309161 |
| 184 | adult walking behavior (GO:0007628) | 2.22304892 |
| 185 | long-term synaptic potentiation (GO:0060291) | 2.21887839 |
| 186 | retina layer formation (GO:0010842) | 2.21195997 |
| 187 | synaptic vesicle maturation (GO:0016188) | 2.19140147 |
| 188 | intraciliary transport (GO:0042073) | 2.19134367 |
| 189 | regulation of respiratory gaseous exchange (GO:0043576) | 2.18579543 |
| 190 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 2.17504822 |
| 191 | membrane hyperpolarization (GO:0060081) | 2.17155257 |
| 192 | photoreceptor cell development (GO:0042461) | 2.15882879 |
| 193 | nonmotile primary cilium assembly (GO:0035058) | 2.15631971 |
| 194 | neuron recognition (GO:0008038) | 2.15418483 |
| 195 | membrane depolarization (GO:0051899) | 2.14923039 |
| 196 | synaptic vesicle endocytosis (GO:0048488) | 2.13016503 |
| 197 | calcium ion import (GO:0070509) | 2.12386040 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.58661460 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 4.27532177 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.60021150 |
| 4 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.63686701 |
| 5 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.56405639 |
| 6 | VDR_22108803_ChIP-Seq_LS180_Human | 2.46497996 |
| 7 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.30789832 |
| 8 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.24046529 |
| 9 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.23387741 |
| 10 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.23178194 |
| 11 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.12647654 |
| 12 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.05409183 |
| 13 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.04205103 |
| 14 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 2.03782988 |
| 15 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.99967217 |
| 16 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.98155472 |
| 17 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.94683896 |
| 18 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.93834665 |
| 19 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.89059863 |
| 20 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.87910587 |
| 21 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.87910587 |
| 22 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.86932698 |
| 23 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.86849049 |
| 24 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.86719947 |
| 25 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.86535849 |
| 26 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.84436628 |
| 27 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.82173248 |
| 28 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.82156157 |
| 29 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.78465379 |
| 30 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.78419806 |
| 31 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.75147864 |
| 32 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.74688766 |
| 33 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.74196644 |
| 34 | P300_19829295_ChIP-Seq_ESCs_Human | 1.73827095 |
| 35 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.73550541 |
| 36 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.73326692 |
| 37 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.72867606 |
| 38 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.70675152 |
| 39 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.69867422 |
| 40 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.66500560 |
| 41 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.65500245 |
| 42 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.63452163 |
| 43 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.63298558 |
| 44 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.61979684 |
| 45 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.61231602 |
| 46 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.60964071 |
| 47 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.60851259 |
| 48 | GATA3_26560356_Chip-Seq_TH2_Human | 1.59195201 |
| 49 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.58256679 |
| 50 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.56708692 |
| 51 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.56163752 |
| 52 | FUS_26573619_Chip-Seq_HEK293_Human | 1.56099175 |
| 53 | MYB_26560356_Chip-Seq_TH2_Human | 1.55416211 |
| 54 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.54636910 |
| 55 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.54310687 |
| 56 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.54063893 |
| 57 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.53989807 |
| 58 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.53321912 |
| 59 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.53035046 |
| 60 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.52626801 |
| 61 | * CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.51993628 |
| 62 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.50664518 |
| 63 | * CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.50407544 |
| 64 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.50199491 |
| 65 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.49843333 |
| 66 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.49639271 |
| 67 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.49392808 |
| 68 | GATA1_22025678_ChIP-Seq_K562_Human | 1.48677574 |
| 69 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.48281892 |
| 70 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.47710972 |
| 71 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.46782478 |
| 72 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.45580751 |
| 73 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.45098089 |
| 74 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.44977910 |
| 75 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.44877589 |
| 76 | STAT3_23295773_ChIP-Seq_U87_Human | 1.43087746 |
| 77 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.42540215 |
| 78 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.41960163 |
| 79 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.41879657 |
| 80 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.41524070 |
| 81 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.40775464 |
| 82 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.40509788 |
| 83 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.40079471 |
| 84 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.39923284 |
| 85 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.39871287 |
| 86 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 1.38688468 |
| 87 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.38073623 |
| 88 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.37704198 |
| 89 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.36595598 |
| 90 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.36404621 |
| 91 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.36111768 |
| 92 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.36111768 |
| 93 | TCF4_23295773_ChIP-Seq_U87_Human | 1.36101918 |
| 94 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.33329827 |
| 95 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.32782199 |
| 96 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.32771203 |
| 97 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.32705582 |
| 98 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.32705582 |
| 99 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.32539622 |
| 100 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.31335098 |
| 101 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.30957407 |
| 102 | * VDR_23849224_ChIP-Seq_CD4+_Human | 1.30678906 |
| 103 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.29236487 |
| 104 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.29023422 |
| 105 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.28933647 |
| 106 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.28379309 |
| 107 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 1.28314380 |
| 108 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.28273942 |
| 109 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.28217667 |
| 110 | AR_25329375_ChIP-Seq_VCAP_Human | 1.27419787 |
| 111 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 1.27240881 |
| 112 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.26696736 |
| 113 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.26581843 |
| 114 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.26147233 |
| 115 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.25897676 |
| 116 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.24923383 |
| 117 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.24458790 |
| 118 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 1.23779215 |
| 119 | PU1_27457419_Chip-Seq_LIVER_Mouse | 1.23711036 |
| 120 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 1.23491060 |
| 121 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.23439082 |
| 122 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.22787135 |
| 123 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.21434667 |
| 124 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.21002518 |
| 125 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.19748847 |
| 126 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.18362446 |
| 127 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.18362446 |
| 128 | CTCF_18555785_Chip-Seq_ESCs_Mouse | 1.17887238 |
| 129 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.17840307 |
| 130 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.17365178 |
| 131 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.17324215 |
| 132 | ZFX_18555785_Chip-Seq_ESCs_Mouse | 1.16858788 |
| 133 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.16185553 |
| 134 | KLF4_18555785_Chip-Seq_ESCs_Mouse | 1.16054255 |
| 135 | EWS_26573619_Chip-Seq_HEK293_Human | 1.15826710 |
| 136 | TP53_16413492_ChIP-PET_HCT116_Human | 1.15691932 |
| 137 | ESRRB_18555785_Chip-Seq_ESCs_Mouse | 1.14945743 |
| 138 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.14623922 |
| 139 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.12989298 |
| 140 | * TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.12688041 |
| 141 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.12578472 |
| 142 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.12396398 |
| 143 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 1.10980770 |
| 144 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.10515662 |
| 145 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.10078735 |
| 146 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.09682593 |
| 147 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.08885714 |
| 148 | KDM2B_26808549_Chip-Seq_REH_Human | 1.08860576 |
| 149 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.08027305 |
| 150 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.07085997 |
| 151 | SMRT_27268052_Chip-Seq_Bcells_Human | 1.06649322 |
| 152 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.05737160 |
| 153 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.05693168 |
| 154 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.04525096 |
| 155 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.03574528 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0006292_abnormal_olfactory_placode | 3.94714104 |
| 2 | MP0001188_hyperpigmentation | 3.64986425 |
| 3 | MP0003880_abnormal_central_pattern | 3.46421397 |
| 4 | MP0003787_abnormal_imprinting | 3.37770101 |
| 5 | MP0005409_darkened_coat_color | 2.99947150 |
| 6 | MP0004859_abnormal_synaptic_plasticity | 2.73708360 |
| 7 | MP0000569_abnormal_digit_pigmentation | 2.72772786 |
| 8 | MP0003724_increased_susceptibility_to | 2.65070769 |
| 9 | MP0000015_abnormal_ear_pigmentation | 2.48716360 |
| 10 | MP0003195_calcinosis | 2.42462812 |
| 11 | MP0005646_abnormal_pituitary_gland | 2.33380688 |
| 12 | MP0001486_abnormal_startle_reflex | 2.29889181 |
| 13 | MP0001800_abnormal_humoral_immune | 2.22664190 |
| 14 | MP0003635_abnormal_synaptic_transmissio | 2.18327899 |
| 15 | MP0005174_abnormal_tail_pigmentation | 2.13265869 |
| 16 | MP0005171_absent_coat_pigmentation | 2.11973732 |
| 17 | MP0003763_abnormal_thymus_physiology | 2.11499961 |
| 18 | MP0003136_yellow_coat_color | 2.07331631 |
| 19 | MP0002166_altered_tumor_susceptibility | 2.05979869 |
| 20 | MP0009745_abnormal_behavioral_response | 2.04212889 |
| 21 | MP0005645_abnormal_hypothalamus_physiol | 2.02163414 |
| 22 | MP0000566_synostosis | 1.99508340 |
| 23 | MP0005551_abnormal_eye_electrophysiolog | 1.93196474 |
| 24 | MP0001502_abnormal_circadian_rhythm | 1.87975005 |
| 25 | MP0002837_dystrophic_cardiac_calcinosis | 1.87759645 |
| 26 | MP0009046_muscle_twitch | 1.86014745 |
| 27 | MP0002723_abnormal_immune_serum | 1.84906865 |
| 28 | MP0003183_abnormal_peptide_metabolism | 1.83936706 |
| 29 | MP0009785_altered_susceptibility_to | 1.83112455 |
| 30 | MP0005423_abnormal_somatic_nervous | 1.80222907 |
| 31 | MP0005000_abnormal_immune_tolerance | 1.79907119 |
| 32 | MP0002272_abnormal_nervous_system | 1.78506214 |
| 33 | MP0002452_abnormal_antigen_presenting | 1.77398599 |
| 34 | MP0008877_abnormal_DNA_methylation | 1.74006267 |
| 35 | MP0002064_seizures | 1.72781046 |
| 36 | MP0000685_abnormal_immune_system | 1.71654321 |
| 37 | MP0002420_abnormal_adaptive_immunity | 1.71556594 |
| 38 | MP0002638_abnormal_pupillary_reflex | 1.71329287 |
| 39 | MP0001819_abnormal_immune_cell | 1.70308754 |
| 40 | MP0001790_abnormal_immune_system | 1.66296942 |
| 41 | MP0005387_immune_system_phenotype | 1.66296942 |
| 42 | MP0001968_abnormal_touch/_nociception | 1.63316620 |
| 43 | MP0002063_abnormal_learning/memory/cond | 1.62706989 |
| 44 | MP0002148_abnormal_hypersensitivity_rea | 1.62671745 |
| 45 | MP0002067_abnormal_sensory_capabilities | 1.62349961 |
| 46 | MP0002572_abnormal_emotion/affect_behav | 1.58151226 |
| 47 | MP0002009_preneoplasia | 1.56899011 |
| 48 | MP0002419_abnormal_innate_immunity | 1.55051947 |
| 49 | MP0004742_abnormal_vestibular_system | 1.54778272 |
| 50 | MP0001986_abnormal_taste_sensitivity | 1.53288496 |
| 51 | MP0002006_tumorigenesis | 1.52799102 |
| 52 | MP0002557_abnormal_social/conspecific_i | 1.50081112 |
| 53 | MP0005310_abnormal_salivary_gland | 1.47658012 |
| 54 | MP0005025_abnormal_response_to | 1.47498461 |
| 55 | MP0003646_muscle_fatigue | 1.44199443 |
| 56 | MP0000778_abnormal_nervous_system | 1.43798199 |
| 57 | MP0006082_CNS_inflammation | 1.41766135 |
| 58 | MP0002095_abnormal_skin_pigmentation | 1.41362425 |
| 59 | MP0002405_respiratory_system_inflammati | 1.41291712 |
| 60 | MP0008569_lethality_at_weaning | 1.40987184 |
| 61 | MP0009764_decreased_sensitivity_to | 1.40071880 |
| 62 | MP0002876_abnormal_thyroid_physiology | 1.38972765 |
| 63 | MP0000716_abnormal_immune_system | 1.37554002 |
| 64 | MP0000689_abnormal_spleen_morphology | 1.37093746 |
| 65 | MP0003252_abnormal_bile_duct | 1.36308452 |
| 66 | MP0002398_abnormal_bone_marrow | 1.35656307 |
| 67 | MP0005253_abnormal_eye_physiology | 1.34336357 |
| 68 | MP0008875_abnormal_xenobiotic_pharmacok | 1.34164730 |
| 69 | MP0001501_abnormal_sleep_pattern | 1.32360699 |
| 70 | MP0008057_abnormal_DNA_replication | 1.31756500 |
| 71 | MP0004147_increased_porphyrin_level | 1.31317377 |
| 72 | MP0004270_analgesia | 1.31186339 |
| 73 | MP0000631_abnormal_neuroendocrine_gland | 1.30695606 |
| 74 | MP0002734_abnormal_mechanical_nocicepti | 1.28125359 |
| 75 | MP0006072_abnormal_retinal_apoptosis | 1.27357225 |
| 76 | MP0003436_decreased_susceptibility_to | 1.23999175 |
| 77 | MP0003121_genomic_imprinting | 1.22449340 |
| 78 | MP0000427_abnormal_hair_cycle | 1.22448945 |
| 79 | MP0002102_abnormal_ear_morphology | 1.21526027 |
| 80 | MP0001984_abnormal_olfaction | 1.20913366 |
| 81 | MP0001963_abnormal_hearing_physiology | 1.18671870 |
| 82 | MP0003656_abnormal_erythrocyte_physiolo | 1.17964238 |
| 83 | MP0002736_abnormal_nociception_after | 1.17467014 |
| 84 | MP0005464_abnormal_platelet_physiology | 1.16883567 |
| 85 | MP0001845_abnormal_inflammatory_respons | 1.16799691 |
| 86 | MP0003122_maternal_imprinting | 1.16769679 |
| 87 | MP0001545_abnormal_hematopoietic_system | 1.14250886 |
| 88 | MP0005397_hematopoietic_system_phenotyp | 1.14250886 |
| 89 | MP0010386_abnormal_urinary_bladder | 1.12834251 |
| 90 | MP0001873_stomach_inflammation | 1.12090807 |
| 91 | MP0003011_delayed_dark_adaptation | 1.10683800 |
| 92 | MP0004142_abnormal_muscle_tone | 1.09903553 |
| 93 | MP0003879_abnormal_hair_cell | 1.09697620 |
| 94 | MP0002722_abnormal_immune_system | 1.09311750 |
| 95 | MP0009780_abnormal_chondrocyte_physiolo | 1.08182095 |
| 96 | MP0002396_abnormal_hematopoietic_system | 1.08180139 |
| 97 | MP0002184_abnormal_innervation | 1.07507371 |
| 98 | MP0002693_abnormal_pancreas_physiology | 1.07182482 |
| 99 | MP0002249_abnormal_larynx_morphology | 1.07141902 |
| 100 | MP0000026_abnormal_inner_ear | 1.05757919 |
| 101 | MP0002882_abnormal_neuron_morphology | 1.05059946 |
| 102 | MP0001835_abnormal_antigen_presentation | 1.04591030 |
| 103 | MP0002138_abnormal_hepatobiliary_system | 1.04520209 |
| 104 | MP0000372_irregular_coat_pigmentation | 1.02971550 |
| 105 | MP0003045_fibrosis | 1.02116549 |
| 106 | MP0008260_abnormal_autophagy | 1.01165013 |
| 107 | MP0008872_abnormal_physiological_respon | 1.00788537 |
| 108 | MP0004924_abnormal_behavior | 1.00030877 |
| 109 | MP0005386_behavior/neurological_phenoty | 1.00030877 |
| 110 | MP0002928_abnormal_bile_duct | 0.99757555 |
| 111 | MP0001764_abnormal_homeostasis | 0.99497324 |
| 112 | MP0002429_abnormal_blood_cell | 0.98934654 |
| 113 | MP0008469_abnormal_protein_level | 0.97096673 |
| 114 | MP0005075_abnormal_melanosome_morpholog | 0.96020392 |
| 115 | MP0010155_abnormal_intestine_physiology | 0.95377171 |
| 116 | MP0004043_abnormal_pH_regulation | 0.94807487 |
| 117 | MP0003172_abnormal_lysosome_physiology | 0.94766524 |
| 118 | MP0001970_abnormal_pain_threshold | 0.94731816 |
| 119 | MP0002822_catalepsy | 0.94276293 |
| 120 | MP0006276_abnormal_autonomic_nervous | 0.93721244 |
| 121 | MP0001440_abnormal_grooming_behavior | 0.92457893 |
| 122 | MP0004484_altered_response_of | 0.92401838 |
| 123 | MP0002277_abnormal_respiratory_mucosa | 0.91963913 |
| 124 | MP0002752_abnormal_somatic_nervous | 0.91937840 |
| 125 | MP0000681_abnormal_thyroid_gland | 0.91843568 |
| 126 | MP0000703_abnormal_thymus_morphology | 0.91464678 |
| 127 | MP0002229_neurodegeneration | 0.91093627 |
| 128 | MP0002735_abnormal_chemical_nociception | 0.90173212 |
| 129 | MP0002163_abnormal_gland_morphology | 0.89846189 |
| 130 | MP0005389_reproductive_system_phenotype | 0.88341118 |
| 131 | MP0004885_abnormal_endolymph | 0.87898932 |
| 132 | MP0004381_abnormal_hair_follicle | 0.87438785 |
| 133 | MP0008961_abnormal_basal_metabolism | 0.87093499 |
| 134 | MP0005084_abnormal_gallbladder_morpholo | 0.86743348 |
| 135 | MP0000678_abnormal_parathyroid_gland | 0.86478076 |
| 136 | MP0002177_abnormal_outer_ear | 0.86006539 |
| 137 | MP0005671_abnormal_response_to | 0.85108898 |
| 138 | MP0002733_abnormal_thermal_nociception | 0.83745958 |
| 139 | MP0000955_abnormal_spinal_cord | 0.83105688 |
| 140 | MP0001324_abnormal_eye_pigmentation | 0.81637301 |
| 141 | MP0003690_abnormal_glial_cell | 0.80803276 |
| 142 | MP0003943_abnormal_hepatobiliary_system | 0.79173650 |
| 143 | MP0003303_peritoneal_inflammation | 0.78373047 |
| 144 | MP0001177_atelectasis | 0.78155289 |
| 145 | MP0001919_abnormal_reproductive_system | 0.77417918 |
| 146 | MP0005195_abnormal_posterior_eye | 0.75679775 |
| 147 | MP0003866_abnormal_defecation | 0.75200944 |
| 148 | MP0005167_abnormal_blood-brain_barrier | 0.74054929 |
| 149 | MP0008995_early_reproductive_senescence | 0.73457448 |
| 150 | MP0002066_abnormal_motor_capabilities/c | 0.73273994 |
| 151 | MP0000465_gastrointestinal_hemorrhage | 0.72494820 |
| 152 | MP0005379_endocrine/exocrine_gland_phen | 0.71491291 |
| 153 | MP0000049_abnormal_middle_ear | 0.71302582 |
| 154 | MP0002075_abnormal_coat/hair_pigmentati | 0.70703112 |
| 155 | MP0000920_abnormal_myelination | 0.69627892 |
| 156 | MP0005647_abnormal_sex_gland | 0.69046682 |
| 157 | MP0001186_pigmentation_phenotype | 0.67817940 |
| 158 | MP0001485_abnormal_pinna_reflex | 0.67063459 |
| 159 | MP0004145_abnormal_muscle_electrophysio | 0.66603905 |
| 160 | MP0003633_abnormal_nervous_system | 0.64446858 |
| 161 | MP0004811_abnormal_neuron_physiology | 0.64441239 |
| 162 | MP0000230_abnormal_systemic_arterial | 0.61535288 |
| 163 | MP0001765_abnormal_ion_homeostasis | 0.60810688 |
| 164 | MP0003786_premature_aging | 0.60094767 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 4.29757070 |
| 2 | Febrile seizures (HP:0002373) | 4.20363046 |
| 3 | Pancreatic cysts (HP:0001737) | 3.60663302 |
| 4 | Stomatitis (HP:0010280) | 3.52417364 |
| 5 | Epileptic encephalopathy (HP:0200134) | 3.25085811 |
| 6 | Abnormality of the renal cortex (HP:0011035) | 3.22683593 |
| 7 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.15028144 |
| 8 | Renal cortical cysts (HP:0000803) | 3.05838924 |
| 9 | Abolished electroretinogram (ERG) (HP:0000550) | 2.93474990 |
| 10 | Decreased central vision (HP:0007663) | 2.90722602 |
| 11 | Septo-optic dysplasia (HP:0100842) | 2.90227337 |
| 12 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.87763116 |
| 13 | Absent/shortened dynein arms (HP:0200106) | 2.87763116 |
| 14 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.87745717 |
| 15 | Recurrent cutaneous fungal infections (HP:0011370) | 2.85357960 |
| 16 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.85357960 |
| 17 | Gaze-evoked nystagmus (HP:0000640) | 2.85279946 |
| 18 | T lymphocytopenia (HP:0005403) | 2.83584107 |
| 19 | Congenital stationary night blindness (HP:0007642) | 2.83292633 |
| 20 | Abnormality of T cell number (HP:0011839) | 2.81840540 |
| 21 | Retrobulbar optic neuritis (HP:0100654) | 2.80110283 |
| 22 | Optic neuritis (HP:0100653) | 2.80110283 |
| 23 | Abnormality of the prostate (HP:0008775) | 2.78665887 |
| 24 | Hypothermia (HP:0002045) | 2.70852592 |
| 25 | Attenuation of retinal blood vessels (HP:0007843) | 2.64911676 |
| 26 | Polydipsia (HP:0001959) | 2.58707573 |
| 27 | Abnormal drinking behavior (HP:0030082) | 2.58707573 |
| 28 | Broad-based gait (HP:0002136) | 2.56669058 |
| 29 | Panhypogammaglobulinemia (HP:0003139) | 2.56574840 |
| 30 | Optic nerve hypoplasia (HP:0000609) | 2.56137794 |
| 31 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.54396887 |
| 32 | Nephronophthisis (HP:0000090) | 2.53638811 |
| 33 | Myositis (HP:0100614) | 2.52726523 |
| 34 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.50155114 |
| 35 | Thyroiditis (HP:0100646) | 2.49904321 |
| 36 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 2.49886598 |
| 37 | Congenital sensorineural hearing impairment (HP:0008527) | 2.47204050 |
| 38 | Abnormality of the renal medulla (HP:0100957) | 2.46360424 |
| 39 | True hermaphroditism (HP:0010459) | 2.45757289 |
| 40 | Stomach cancer (HP:0012126) | 2.44984303 |
| 41 | Large for gestational age (HP:0001520) | 2.44047452 |
| 42 | Patchy hypopigmentation of hair (HP:0011365) | 2.43881918 |
| 43 | Protruding tongue (HP:0010808) | 2.43845341 |
| 44 | Prostate neoplasm (HP:0100787) | 2.41793515 |
| 45 | Orchitis (HP:0100796) | 2.41612128 |
| 46 | Nonprogressive disorder (HP:0003680) | 2.40604732 |
| 47 | Hypoplasia of the fovea (HP:0007750) | 2.39305064 |
| 48 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 2.39305064 |
| 49 | Recurrent fungal infections (HP:0002841) | 2.35111559 |
| 50 | Abnormality of the fovea (HP:0000493) | 2.34427470 |
| 51 | Severe visual impairment (HP:0001141) | 2.34131753 |
| 52 | Keratoconus (HP:0000563) | 2.31913822 |
| 53 | Increased corneal curvature (HP:0100692) | 2.31913822 |
| 54 | Tubulointerstitial nephritis (HP:0001970) | 2.31708302 |
| 55 | Focal seizures (HP:0007359) | 2.31446752 |
| 56 | Abnormality of T cells (HP:0002843) | 2.30820276 |
| 57 | Generalized hypopigmentation of hair (HP:0011358) | 2.29575758 |
| 58 | Chromsome breakage (HP:0040012) | 2.28328151 |
| 59 | White forelock (HP:0002211) | 2.25464207 |
| 60 | Progressive cerebellar ataxia (HP:0002073) | 2.23573999 |
| 61 | IgG deficiency (HP:0004315) | 2.20492778 |
| 62 | Chronic hepatic failure (HP:0100626) | 2.19910616 |
| 63 | Fair hair (HP:0002286) | 2.19562429 |
| 64 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.19174298 |
| 65 | Absent septum pellucidum (HP:0001331) | 2.16008025 |
| 66 | Encephalitis (HP:0002383) | 2.15900550 |
| 67 | Chronic otitis media (HP:0000389) | 2.15560632 |
| 68 | Abnormality of macular pigmentation (HP:0008002) | 2.15046038 |
| 69 | Bony spicule pigmentary retinopathy (HP:0007737) | 2.14311578 |
| 70 | Medial flaring of the eyebrow (HP:0010747) | 2.14103619 |
| 71 | Keratoconjunctivitis (HP:0001096) | 2.13513134 |
| 72 | Pancreatic fibrosis (HP:0100732) | 2.10691342 |
| 73 | Scanning speech (HP:0002168) | 2.10027782 |
| 74 | Action tremor (HP:0002345) | 2.09846615 |
| 75 | Abnormality of B cell number (HP:0010975) | 2.08798784 |
| 76 | Bile duct proliferation (HP:0001408) | 2.06135973 |
| 77 | Abnormal biliary tract physiology (HP:0012439) | 2.06135973 |
| 78 | Abnormality of the nasal septum (HP:0000419) | 2.05501285 |
| 79 | Widely spaced teeth (HP:0000687) | 2.05229149 |
| 80 | Hemoptysis (HP:0002105) | 2.03272794 |
| 81 | Constricted visual fields (HP:0001133) | 2.02750498 |
| 82 | Abnormal hair whorl (HP:0010721) | 2.02299307 |
| 83 | Abnormality of T cell physiology (HP:0011840) | 2.02014403 |
| 84 | Intestinal atresia (HP:0011100) | 2.01993345 |
| 85 | Molar tooth sign on MRI (HP:0002419) | 1.99339847 |
| 86 | Abnormality of midbrain morphology (HP:0002418) | 1.99339847 |
| 87 | Recurrent skin infections (HP:0001581) | 1.99286106 |
| 88 | Vasculitis (HP:0002633) | 1.98223324 |
| 89 | Median cleft lip (HP:0000161) | 1.97618057 |
| 90 | Dyschromatopsia (HP:0007641) | 1.97383844 |
| 91 | Gait imbalance (HP:0002141) | 1.97183176 |
| 92 | Hypokalemic alkalosis (HP:0001949) | 1.96937773 |
| 93 | Hyperventilation (HP:0002883) | 1.96870042 |
| 94 | Abnormality of eosinophils (HP:0001879) | 1.96865368 |
| 95 | Progressive inability to walk (HP:0002505) | 1.96534669 |
| 96 | Absent speech (HP:0001344) | 1.96201765 |
| 97 | Recurrent bacterial skin infections (HP:0005406) | 1.95880503 |
| 98 | Blue irides (HP:0000635) | 1.95787255 |
| 99 | Polyuria (HP:0000103) | 1.94667616 |
| 100 | Pulmonary infiltrates (HP:0002113) | 1.93609430 |
| 101 | Recurrent bronchitis (HP:0002837) | 1.93527038 |
| 102 | Thyroid-stimulating hormone excess (HP:0002925) | 1.89324467 |
| 103 | Macular degeneration (HP:0000608) | 1.88308445 |
| 104 | Dysdiadochokinesis (HP:0002075) | 1.87886122 |
| 105 | Furrowed tongue (HP:0000221) | 1.87617966 |
| 106 | Aplasia/Hypoplasia of the optic nerve (HP:0008058) | 1.87357476 |
| 107 | Postaxial foot polydactyly (HP:0001830) | 1.87335482 |
| 108 | Hypoplastic iliac wings (HP:0002866) | 1.87121331 |
| 109 | Congenital primary aphakia (HP:0007707) | 1.86748109 |
| 110 | Central scotoma (HP:0000603) | 1.86149345 |
| 111 | Cystic liver disease (HP:0006706) | 1.85390490 |
| 112 | Abnormality of incisor morphology (HP:0011063) | 1.84690470 |
| 113 | Keratoconjunctivitis sicca (HP:0001097) | 1.84159079 |
| 114 | Decreased lacrimation (HP:0000633) | 1.83103524 |
| 115 | Type I transferrin isoform profile (HP:0003642) | 1.82894067 |
| 116 | Genital tract atresia (HP:0001827) | 1.82745395 |
| 117 | Abnormal ciliary motility (HP:0012262) | 1.82725696 |
| 118 | Ketosis (HP:0001946) | 1.82708506 |
| 119 | Hematochezia (HP:0002573) | 1.82275485 |
| 120 | Albinism (HP:0001022) | 1.82034133 |
| 121 | Hypochromic microcytic anemia (HP:0004840) | 1.81478929 |
| 122 | Neoplasm of the tracheobronchial system (HP:0100552) | 1.81387363 |
| 123 | Inability to walk (HP:0002540) | 1.80981195 |
| 124 | Congenital hepatic fibrosis (HP:0002612) | 1.79795730 |
| 125 | Nephrogenic diabetes insipidus (HP:0009806) | 1.79610602 |
| 126 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.79465137 |
| 127 | Pustule (HP:0200039) | 1.78471089 |
| 128 | Excessive salivation (HP:0003781) | 1.78040008 |
| 129 | Drooling (HP:0002307) | 1.78040008 |
| 130 | Abnormality of the septum pellucidum (HP:0007375) | 1.78015380 |
| 131 | Gastrointestinal infarctions (HP:0005244) | 1.77409351 |
| 132 | Meningitis (HP:0001287) | 1.77360537 |
| 133 | Alveolar cell carcinoma (HP:0006519) | 1.77308668 |
| 134 | Atonic seizures (HP:0010819) | 1.76741813 |
| 135 | Severe combined immunodeficiency (HP:0004430) | 1.76381944 |
| 136 | Long nose (HP:0003189) | 1.76306225 |
| 137 | Recurrent abscess formation (HP:0002722) | 1.76286706 |
| 138 | Abnormality of DNA repair (HP:0003254) | 1.75766193 |
| 139 | Leukocytosis (HP:0001974) | 1.75610108 |
| 140 | Metabolic alkalosis (HP:0200114) | 1.74901497 |
| 141 | Vaginal atresia (HP:0000148) | 1.74522595 |
| 142 | Poor coordination (HP:0002370) | 1.74288357 |
| 143 | Arterial thrombosis (HP:0004420) | 1.74129579 |
| 144 | Agammaglobulinemia (HP:0004432) | 1.73313555 |
| 145 | Chronic diarrhea (HP:0002028) | 1.73152097 |
| 146 | Ketoacidosis (HP:0001993) | 1.72359855 |
| 147 | Abnormality of male internal genitalia (HP:0000022) | 1.71455180 |
| 148 | Metaphyseal dysplasia (HP:0100255) | 1.71357085 |
| 149 | Absent frontal sinuses (HP:0002688) | 1.71186203 |
| 150 | Type II lissencephaly (HP:0007260) | 1.71038002 |
| 151 | Macroorchidism (HP:0000053) | 1.65774952 |
| 152 | Alacrima (HP:0000522) | 1.65365303 |
| 153 | Stage 5 chronic kidney disease (HP:0003774) | 1.64352753 |
| 154 | Photophobia (HP:0000613) | 1.64289444 |
| 155 | Hemiparesis (HP:0001269) | 1.62514410 |
| 156 | Abnormality of salivation (HP:0100755) | 1.61656739 |
| 157 | Lip pit (HP:0100267) | 1.61079536 |
| 158 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 1.60030515 |
| 159 | Aplasia/Hypoplasia affecting the fundus (HP:0008057) | 1.59738603 |
| 160 | Decreased circulating renin level (HP:0003351) | 1.59730006 |
| 161 | Aplasia/Hypoplasia of the lens (HP:0008063) | 1.59413587 |
| 162 | Acute lymphatic leukemia (HP:0006721) | 1.58246016 |
| 163 | Preaxial hand polydactyly (HP:0001177) | 1.57267455 |
| 164 | Growth hormone deficiency (HP:0000824) | 1.57174566 |
| 165 | Astigmatism (HP:0000483) | 1.57037578 |
| 166 | Tented upper lip vermilion (HP:0010804) | 1.56903354 |
| 167 | Renal dysplasia (HP:0000110) | 1.56810853 |
| 168 | Inappropriate behavior (HP:0000719) | 1.56699324 |
| 169 | Aplasia cutis congenita (HP:0001057) | 1.55285057 |
| 170 | Midline defect of the nose (HP:0004122) | 1.52264891 |
| 171 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 1.51672086 |
| 172 | Cortical visual impairment (HP:0100704) | 1.50404926 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FRK | 6.30851173 |
| 2 | CASK | 4.48161218 |
| 3 | TNIK | 4.39944303 |
| 4 | NEK6 | 3.17274518 |
| 5 | TAOK3 | 3.10748693 |
| 6 | MAP2K7 | 2.56878505 |
| 7 | NTRK3 | 2.54292946 |
| 8 | MUSK | 2.45197169 |
| 9 | EPHA4 | 2.39134096 |
| 10 | MAP4K2 | 2.31461484 |
| 11 | PRPF4B | 2.30336106 |
| 12 | MKNK2 | 2.17460018 |
| 13 | INSRR | 2.14202554 |
| 14 | MAPK13 | 1.90470875 |
| 15 | TXK | 1.82528266 |
| 16 | YES1 | 1.80741505 |
| 17 | FES | 1.69836093 |
| 18 | IRAK4 | 1.69476859 |
| 19 | SGK2 | 1.66661089 |
| 20 | BMPR1B | 1.61414433 |
| 21 | ACVR1B | 1.60668090 |
| 22 | BLK | 1.57258594 |
| 23 | CDK3 | 1.56500279 |
| 24 | MAP3K14 | 1.47992714 |
| 25 | MAP4K1 | 1.45843606 |
| 26 | EIF2AK3 | 1.42387509 |
| 27 | SYK | 1.40141480 |
| 28 | MKNK1 | 1.36099539 |
| 29 | TLK1 | 1.31920774 |
| 30 | MARK1 | 1.30916966 |
| 31 | ITK | 1.30640299 |
| 32 | ZAK | 1.27718214 |
| 33 | MST4 | 1.25101273 |
| 34 | TNK2 | 1.24591844 |
| 35 | ADRBK2 | 1.23860381 |
| 36 | AKT3 | 1.22512900 |
| 37 | SGK223 | 1.21160590 |
| 38 | SGK494 | 1.21160590 |
| 39 | NUAK1 | 1.18127880 |
| 40 | ERBB3 | 1.16973549 |
| 41 | CLK1 | 1.08465680 |
| 42 | CAMKK2 | 1.07307023 |
| 43 | NTRK2 | 1.06085640 |
| 44 | PIK3CG | 1.05541450 |
| 45 | PRKCQ | 1.05077601 |
| 46 | IRAK2 | 1.04846286 |
| 47 | TRIM28 | 1.03022727 |
| 48 | SGK3 | 1.02944700 |
| 49 | TYK2 | 1.02818158 |
| 50 | SIK2 | 1.00692591 |
| 51 | IRAK1 | 1.00495699 |
| 52 | BMPR2 | 1.00120843 |
| 53 | BCKDK | 0.99737824 |
| 54 | DAPK2 | 0.99719458 |
| 55 | JAK1 | 0.99636083 |
| 56 | IRAK3 | 0.99546157 |
| 57 | BRSK2 | 0.99097959 |
| 58 | TRPM7 | 0.98840361 |
| 59 | PDK2 | 0.98035228 |
| 60 | PIK3CA | 0.97645410 |
| 61 | CAMK1G | 0.97411089 |
| 62 | NLK | 0.96536703 |
| 63 | CAMK1 | 0.95825718 |
| 64 | STK16 | 0.94584737 |
| 65 | MAP3K13 | 0.93441724 |
| 66 | LCK | 0.92349705 |
| 67 | BRD4 | 0.92044001 |
| 68 | STK38 | 0.90998835 |
| 69 | MARK3 | 0.90922004 |
| 70 | FGR | 0.89885802 |
| 71 | RIPK4 | 0.85757395 |
| 72 | KIT | 0.84775151 |
| 73 | MAPK15 | 0.84057820 |
| 74 | PINK1 | 0.82006894 |
| 75 | FLT3 | 0.81732496 |
| 76 | EPHA3 | 0.81692603 |
| 77 | PAK3 | 0.81457196 |
| 78 | DYRK1A | 0.81022433 |
| 79 | TAOK2 | 0.80254152 |
| 80 | MAP2K6 | 0.80058967 |
| 81 | TEC | 0.79567996 |
| 82 | RPS6KA4 | 0.78665606 |
| 83 | GRK1 | 0.78298404 |
| 84 | MAPK7 | 0.78037447 |
| 85 | GRK6 | 0.77539129 |
| 86 | GRK7 | 0.75944649 |
| 87 | ADRBK1 | 0.75357338 |
| 88 | CAMK1D | 0.75209678 |
| 89 | MATK | 0.74293926 |
| 90 | STK39 | 0.72939418 |
| 91 | MAP3K4 | 0.72505260 |
| 92 | IKBKE | 0.72059729 |
| 93 | CCNB1 | 0.70263027 |
| 94 | PKN1 | 0.70163800 |
| 95 | SGK1 | 0.69903530 |
| 96 | CSK | 0.68784340 |
| 97 | EIF2AK2 | 0.68157582 |
| 98 | SRPK1 | 0.67656319 |
| 99 | ZAP70 | 0.65914335 |
| 100 | CSF1R | 0.65215333 |
| 101 | WNK4 | 0.65056442 |
| 102 | MAP3K7 | 0.64863185 |
| 103 | CDK5 | 0.62609080 |
| 104 | TGFBR2 | 0.61124922 |
| 105 | HIPK2 | 0.61018080 |
| 106 | PRKCE | 0.61002367 |
| 107 | PRKCH | 0.59133907 |
| 108 | PTK2B | 0.57673722 |
| 109 | UHMK1 | 0.57467521 |
| 110 | JAK2 | 0.55737054 |
| 111 | FGFR3 | 0.54889787 |
| 112 | CAMKK1 | 0.54456282 |
| 113 | IKBKB | 0.54211065 |
| 114 | JAK3 | 0.53922510 |
| 115 | CDK19 | 0.52306229 |
| 116 | CAMK2A | 0.51947370 |
| 117 | FGFR2 | 0.51635955 |
| 118 | ABL1 | 0.49352301 |
| 119 | VRK1 | 0.49258197 |
| 120 | CAMK4 | 0.49132089 |
| 121 | CHUK | 0.48978650 |
| 122 | STK3 | 0.47935651 |
| 123 | OXSR1 | 0.47486355 |
| 124 | PRKD2 | 0.45746181 |
| 125 | PRKAA2 | 0.45438040 |
| 126 | STK38L | 0.45229692 |
| 127 | WNK1 | 0.45202904 |
| 128 | PRKG1 | 0.44623408 |
| 129 | LYN | 0.44130185 |
| 130 | PIM1 | 0.43382767 |
| 131 | SIK3 | 0.43073206 |
| 132 | TGFBR1 | 0.43053342 |
| 133 | PDK1 | 0.42502777 |
| 134 | WNK3 | 0.41563524 |
| 135 | RPS6KB1 | 0.40982778 |
| 136 | CAMK2B | 0.40603366 |
| 137 | PASK | 0.40064716 |
| 138 | CDK9 | 0.39937455 |
| 139 | HCK | 0.39670982 |
| 140 | TBK1 | 0.39644368 |
| 141 | FER | 0.39430191 |
| 142 | MAPK12 | 0.39066659 |
| 143 | BTK | 0.38599278 |
| 144 | PLK2 | 0.38465584 |
| 145 | CDC42BPA | 0.38463977 |
| 146 | IGF1R | 0.38293452 |
| 147 | STK11 | 0.38293039 |
| 148 | MARK2 | 0.37744935 |
| 149 | PDGFRB | 0.37356268 |
| 150 | DYRK1B | 0.37312047 |
| 151 | TIE1 | 0.36955370 |
| 152 | DMPK | 0.36512102 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 3.01830159 |
| 2 | Morphine addiction_Homo sapiens_hsa05032 | 2.45128454 |
| 3 | Phototransduction_Homo sapiens_hsa04744 | 2.35936484 |
| 4 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 2.22983173 |
| 5 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 2.22592271 |
| 6 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.21016800 |
| 7 | Circadian entrainment_Homo sapiens_hsa04713 | 2.18041306 |
| 8 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.14285415 |
| 9 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.11207017 |
| 10 | GABAergic synapse_Homo sapiens_hsa04727 | 2.06504811 |
| 11 | Olfactory transduction_Homo sapiens_hsa04740 | 1.94549554 |
| 12 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.85811585 |
| 13 | Taste transduction_Homo sapiens_hsa04742 | 1.82151053 |
| 14 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.75070339 |
| 15 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.69208397 |
| 16 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.66099323 |
| 17 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.65245551 |
| 18 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.63919847 |
| 19 | Leishmaniasis_Homo sapiens_hsa05140 | 1.62481509 |
| 20 | Insulin secretion_Homo sapiens_hsa04911 | 1.58893022 |
| 21 | Protein export_Homo sapiens_hsa03060 | 1.57350226 |
| 22 | Salivary secretion_Homo sapiens_hsa04970 | 1.51955589 |
| 23 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.49087518 |
| 24 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.48932874 |
| 25 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.44179786 |
| 26 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.37853860 |
| 27 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.36710476 |
| 28 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.35524602 |
| 29 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.34551677 |
| 30 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.27262458 |
| 31 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.27089206 |
| 32 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.26621604 |
| 33 | Long-term depression_Homo sapiens_hsa04730 | 1.24808146 |
| 34 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.23386768 |
| 35 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.22931026 |
| 36 | Renin secretion_Homo sapiens_hsa04924 | 1.18763433 |
| 37 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.17883810 |
| 38 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.15501123 |
| 39 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.14782578 |
| 40 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.14624371 |
| 41 | Axon guidance_Homo sapiens_hsa04360 | 1.13481419 |
| 42 | Tuberculosis_Homo sapiens_hsa05152 | 1.12882794 |
| 43 | Basal transcription factors_Homo sapiens_hsa03022 | 1.12851551 |
| 44 | Circadian rhythm_Homo sapiens_hsa04710 | 1.12745879 |
| 45 | Cocaine addiction_Homo sapiens_hsa05030 | 1.11973586 |
| 46 | Long-term potentiation_Homo sapiens_hsa04720 | 1.10056544 |
| 47 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.05387418 |
| 48 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.04309260 |
| 49 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.04225951 |
| 50 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.03783706 |
| 51 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.02650546 |
| 52 | Other glycan degradation_Homo sapiens_hsa00511 | 1.02249372 |
| 53 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.98968879 |
| 54 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.97287670 |
| 55 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.91390307 |
| 56 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.90313551 |
| 57 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.90229272 |
| 58 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.89015303 |
| 59 | RNA degradation_Homo sapiens_hsa03018 | 0.88792811 |
| 60 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.87643900 |
| 61 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.86669554 |
| 62 | Peroxisome_Homo sapiens_hsa04146 | 0.85752615 |
| 63 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.83952147 |
| 64 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.82733792 |
| 65 | Legionellosis_Homo sapiens_hsa05134 | 0.82226007 |
| 66 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.82093140 |
| 67 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.81214406 |
| 68 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.80943754 |
| 69 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.80350288 |
| 70 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.79966710 |
| 71 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.79445655 |
| 72 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.79027152 |
| 73 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.78991986 |
| 74 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.77912572 |
| 75 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.77173764 |
| 76 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.76991327 |
| 77 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.76903453 |
| 78 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.76872779 |
| 79 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.76121833 |
| 80 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.75889886 |
| 81 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.74764564 |
| 82 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.74689169 |
| 83 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.74345132 |
| 84 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.73922852 |
| 85 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.73832746 |
| 86 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.73707870 |
| 87 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.73434627 |
| 88 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.72314096 |
| 89 | Homologous recombination_Homo sapiens_hsa03440 | 0.71750514 |
| 90 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.71631555 |
| 91 | Measles_Homo sapiens_hsa05162 | 0.68675420 |
| 92 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.68577876 |
| 93 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.68274254 |
| 94 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.67291830 |
| 95 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.66926745 |
| 96 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.66539059 |
| 97 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.66066422 |
| 98 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.65759438 |
| 99 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.65287392 |
| 100 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.65076047 |
| 101 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.64837429 |
| 102 | Mineral absorption_Homo sapiens_hsa04978 | 0.63588661 |
| 103 | Allograft rejection_Homo sapiens_hsa05330 | 0.62898461 |
| 104 | Melanogenesis_Homo sapiens_hsa04916 | 0.61492500 |
| 105 | Platelet activation_Homo sapiens_hsa04611 | 0.61420070 |
| 106 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.60525285 |
| 107 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.60214718 |
| 108 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.59880906 |
| 109 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.59786187 |
| 110 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.59121697 |
| 111 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.58820872 |
| 112 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.58617978 |
| 113 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.57959751 |
| 114 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.57628597 |
| 115 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.56098338 |
| 116 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.55070537 |
| 117 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.54047077 |
| 118 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.53873860 |
| 119 | Lysosome_Homo sapiens_hsa04142 | 0.53339068 |
| 120 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.52850285 |
| 121 | ABC transporters_Homo sapiens_hsa02010 | 0.52751625 |
| 122 | Influenza A_Homo sapiens_hsa05164 | 0.52732256 |
| 123 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.51785080 |
| 124 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.50823198 |
| 125 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.49026218 |
| 126 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.48922384 |
| 127 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.48798621 |
| 128 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.48305111 |
| 129 | Asthma_Homo sapiens_hsa05310 | 0.48041702 |
| 130 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.47663291 |
| 131 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.47634824 |
| 132 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.46823807 |
| 133 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.46740359 |
| 134 | Malaria_Homo sapiens_hsa05144 | 0.46189057 |
| 135 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.44329899 |
| 136 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.42452796 |
| 137 | Phagosome_Homo sapiens_hsa04145 | 0.36605323 |
| 138 | Viral myocarditis_Homo sapiens_hsa05416 | 0.35806036 |
| 139 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.35632315 |
| 140 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.33383136 |
| 141 | Retinol metabolism_Homo sapiens_hsa00830 | 0.31747612 |

